medigraphic.com
ISSN 1561-3003 (Electronic)

2022, Number 1

<< Back

Rev Cubana Hig Epidemiol 2022; 59 (1)

Prevalence and characteristics of chronic obstructive pulmonary disease in Havana (2017-2018)

Varona PP, Valdés DS, Terry VOM, Valdés AO, Gallego AGC, Venero-Fernández SJ, Molina EE, García OP

Language: Spanish
References: 24
Page: 1-18
PDF size: 359.33 Kb.


ABSTRACT

Introduction: In Cuba, chronic obstructive pulmonary disease is the sixth leading cause of death. There is insufficient knowledge concerning its scope.
Objective: To determine the prevalence and characteristics of the disease in Havana (2017-2018).
Methods: A multicenter, cross-sectional study coordinated by Iniciative Burden of Lung Disease. It included 349 non-hospitalized people aged 40 and over from four family doctor´s offices (random selection). A questionnaire with sociodemographic variables on previous medical diagnosis and smoking was applied. A spirometric study was conducted before and after salbutamol administration to determine airflow limitations, and the disease was classified as mild, moderate, severe, and very severe.
Results: Overall prevalence was 20.9% (95 % CI: 16.6-25.2); with males accounting for 25.3%; and females for 17.7%. It increased with age. Mild forms of the disease affected 60% of the population; they were more common in females (67%) than in males (severe forms, 22%). Previous spirometry was performed in 15% of respondents. Fourteen people (19.1%) had previously been diagnosed with pulmonary emphysema, chronic bronchitis, or chronic obstructive pulmonary disease. Smoking prevalence was 36%, with a higher percentage in the severe forms of the disease. One-third (31.7%) were exposed to second-hand tobacco smoke at home or at work, with a daily average exposure of 5 hours.
Conclusions: Chronic obstructive pulmonary disease is a major health problem in Havana due to its high prevalence and underdiagnosis. An increase in prevalence is predicted given the demographic dynamics in the country and the high level of tobacco consumption among the population. Therefore, more comprehensive management of this preventable disease is required.


REFERENCES

  1. Global Initiative for chronic obstructive lung disease. Global Strategy for Diagnosis, Management and Prevention or Chronic Obstructive pulmonary disease 2018 Report. Estados Unidos: GOLD; 2018 [acceso 22/03/2020]. Disponible en: https://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-FINAL-revised-20-Nov_WMS.pdf1.

  2. Global Initiative for chronic obstructive lung disease. Guía de bolsillo para el diagnóstico, manejo y prevención de la EPOC. Estados Unidos: GOLD; 2021 [acceso 25/03/2021]. Disponible en: https://goldcopd.org/wp-content/uploads/2022/01/GuiasGOLD2022_XXXXXv2_ES-Pocket.pdf2.

  3. Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli GJ, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur Respir J. 2019 [acceso 15/06/2020];53(5):1900164. Disponible en: https://erj.ersjournals.com/content/53/5/19001643.

  4. Martínez Luna M, Rojas Granados A, Lázaro Pacheco RI, Meza Alvarado JE, Ubaldo Reyes L, Ángeles Castellanos M. Enfermedad pulmonar obstructiva crónica (EPOC): Bases para el médico general. Rev Fac Med. (UNAM). 2020 [acceso 16/03/2021];63(3):28-35. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0026-174220200003000284.

  5. Buist AS, Vollmer WM, Sullivan SD, Weiss KB, Lee TA, Menezes AMB, et al. The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. Int J Chron Obstruct Pulmon Dis. 2005 [acceso 11/04/2020];2(2):277-83. Disponible en: https://www.tandfonline.com/doi/full/10.1081/COPD-576105.

  6. Menezes AMB, Perez-Padilla R, Jardim JRB, Muiño A, Lopez MV, Valdivia G, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Content uploaded by Valdivia G. Public full text. Lancet. 2005 [acceso 23/3/2020];366(9500):1875-81. Disponible en: https://www.researchgate.net/publication/7457540_Chronic_obstructive_pulmonary_disease_in_five_Latin_American_cities_the_PLATINO_study_A_prevalence_study6.

  7. Caballero A, Torres-Duque CA, Jaramillo C, Bolívar F, Sanabria F, Osorio P, et al. Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study). Content uploaded by Torres-Duque C. Public full text. Chest. 2008;133:343-9. Prepublished online October 20 2007. DOI: 10.1378/chest.07-13617.

  8. Ministerio de Salud Pública. Dirección Nacional de Registros Médicos y Estadísticas de Salud. Anuario Estadístico de Salud 2017. La Habana: MINSAP; 2018 [acceso 07/05/2021]. Disponible en: https://files.sld.cu/dne/files/2018/04/Anuario-Electronico-Espa%c3%b1ol-2017-ed-2018.pdf8.

  9. Venero Fernández S, Suarez Medina R, Varona Pérez P, Molina Esquivel EE. Mortalidad por enfermedad pulmonar crónica de las vías respiratorias inferiores, Cuba, 1987-2011. Rev Cubana Hig Epidemiol. 2018 [acceso 07/05/2021];56. Disponible en: http://www.revepidemiologia.sld.cu/index.php/hie/article/view/211/2689.

  10. Guevara Lezica R. Estudio epidemiológico de la bronquitis crónica en un sector de Alamar. Pesquisa activa. Policlínico Alamar [tesis]. La Habana: Universidad de La Habana; 1985. [ Links ]

  11. García Castañeda H, Valdés Díaz S, García Silvera E, Fernández García S, Fernández Fernández M. Problemas de salud pulmonar em adultos mayores. Hogar de Santovenia. GEROINFO. 2009 [acceso 18/04/2019];4(3):1-9. Disponible en: https://www.sld.cu/galerias/pdf/sitios/gericuba/salud_pulmonar_en_ancianos.pdf11.

  12. Montes de Oca M, López Varela MV, Laucho-Contreras ME, Casas A, Schiavi E, Rey A, et al. Clasificación de los pacientes con enfermedad pulmonar obstructiva cónica según los sistemas de estadi?cación de la Asociación Latinoamericana de Tórax (ALAT) y la iniciativa global para la enfermedad pulmonar obstructiva crónica (GOLD). Arch Bronconeumol. 2017 [acceso 21/06/2019];53(3):98-106. Disponible en: https://www.archbronconeumol.org/es-clasificacion-pacientes-con-enfermedad-pulmonar-articulo-S030028961630252612.

  13. Asociación Médica Mundial. Declaración de Helsinki de la AMM: Principios éticos para las Investigaciones médicas en seres humanos. Brasil: AMM; 2013 [acceso 12/10/2020]. Disponible en: https://www.fundacionfemeba.org.ar/blog/farmacologia-7/post/declaracion-de-helsinki-2013-declaracion-de-helsinki-de-la-asociacion-medica-mundial-amm-principios-eticos-para-las-investigaciones-medicas-en-seres-humanos-4266913.

  14. Santeliz CJ. Estudio comparativo de la estadificación de pacientes con EPOC según GOLD 2007, 2011 y 2019. Rev Chil Enferm Respir. 2019 [acceso 23/09/2020];35(3):173-80. Disponible en: https://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-7348201900030017314.

  15. García-Gómez A, Ramírez Cruz N, Agüero Carbonell Y, Hernández Torres A, Massó Vicet Y, Martínez Llano Y. Caracterización de pacientes con enfermedad pulmonar obstructiva crónica en la unidad de cuidados intensivos. Rev Cubana Med Milit. 2021 [acceso 13/04/2022];50(4):e02101407. Disponible en: http://www.revmedmilitar.sld.cu/index.php/mil/article/view/140715.

  16. Halpin DMG, Celli BR, Criner GJ, Frith P, López Varela MV, Salvi S, et al. The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries. Int J Tuberc Lung Dis. 2019 [acceso 25/06/2020];23(11):1131-41. Disponible en: https://www.ingentaconnect.com/content/iuatld/ijtld/2019/00000023/00000011/art00003;jsessionid=eojs81erkjeqb.x-ic-live-0316.

  17. Correa S, Gonzaléz M, de Betolaza S, Spiess C, Perera P, Algorta S, et al. Estudio descriptivo de pacientes con EPOC asistidos en medicina interna del Hospital Pasteur de Montevideo: características demográficas y comorbilidades. Rev Urug Med Inter. 2019 [acceso 27/11/2020];(1):5-15. Disponible en: http://www.scielo.edu.uy/scielo.php?script=sci_arttext&pid=S2393-67972019000100005&lng=es&nrm=iso17.

  18. Taussig LM, Wright AL, Holberg CJ, Halonen M, Morgan WJ, Martínez FD. Tucson Children's Respiratory Study: 1980 to present. J Allergy Clin Immunol (abstract). 2003;111(4):661-75. DOI:10.1067/mai.2003.16218.

  19. Gil Rojas Y, Torres Duque CA, Figueredo MC, Hernández F, Castañeda Cardona C, Lasalvia P, et al. Estimación de la prevalencia de EPOC en Colombia a partir del Registro Individual de Prestaciones de Servicios de Salud (RIPS). Rev Colomb. Neumol. 2019 [acceso 03/12/2020];31(1):5-15. Disponible en: https://repository.javeriana.edu.co/handle/10554/5384119.

  20. Soriano JB, Alfageme I, Miravitlles M, de Lucas P, Soler-Cataluña JJ, García-Río F, et al. Prevalence and Determinants of COPD in Spain: EPISCAN II. Arch Bronconeumol. 2021 [acceso 03/12/2020];57(1):61-9. Disponible en: https://www.sciencedirect.com/science/article/pii/S030028962030259320.

  21. Instituto Nacional de Enfermedades Respiratorias (INER) "Emilio Coni". Mortalidad por Enfermedad Pulmonar Obstructiva Crónica (EPOC) d 40 a 74 Años en Argentina. 1980-2015. Argentina: Ministerio de Salud; 2017 [acceso 18/06/2020]. Disponible en: https://docplayer.es/58676197-Mortalidad-por-enfermedad-pulmonar-obstructiva-cronica-epoc-de-40-a-74-anos-en-argentina-resumen.html21.

  22. Valdés Villafranca R, Ramos Cordero AE, Valiente Morejón W, Junco Sena B, Valdés Villafranca R. Mortalidad prematura según causas seleccionadas en el Policlínico "5 de septiembre? Rev Cubana Med Gen Integr. 2021 [acceso 16/08/2020];37(3):e1472. Disponible en: http://www.revmgi.sld.cu/index.php/mgi/article/view/147222.

  23. Yin p, Jiang CQ, Cheng KK, Lam TH, Lam KH, Miller MR, et al. Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study. Lancet. 2007 [acceso 16/08/2021];370:751-7. Disponible en: http://jacobimed.org/public/Docs/Lancet2007VIPs/Passive%20Smoking%20Exposure%20and%20Risk%20of%20COPD%20among%20adults%20in%20China%20-%20Lance%202007.pdf23.

  24. Bonet Gorbea M, Varona Pérez P, Chang La Rosa M, García Rocha RG, Suárez Medina R, Arcia Montes de Oca N, et al. III Encuesta de factores de riesgo y actividades preventivas de enfermedades no transmisibles. Cuba 2010-2011. La Habana: Editorial Ciencias Médicas; 2015 [acceso 16/4/2021]. Disponible en: http://www.bvscuba.sld.cu/libro/iii-encuesta-nacional-de-factores-de-riesgo-y-actividades-preventivas-de-enfermedades-no-trasmisibles-cuba-2010-2011/24.




2020     |     www.medigraphic.com